ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Oral Drug Delivery Market Research Report 2025
Published Date: January 2025
|
Report Code: QYRE-Auto-14E3051
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Oral Drug Delivery Market Insights Forecast to 2028
BUY CHAPTERS

Global Oral Drug Delivery Market Research Report 2025

Code: QYRE-Auto-14E3051
Report
January 2025
Pages:88
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Astrazeneca plc
Mylan N.V.
Sanofi
F. Hoffman-La Roche Ltd.
Bristol Myers Squibb Company
Sun Pharmaceuticals Industries Ltd.
Abbott Laboratories
Merck& Co. Inc
Novartis
Pfizer Inc
Vectura Group plc
GlaxoSmithKline PLC
Johnson & Johnson Services Inc.

Oral Drug Delivery Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Oral Drug Delivery Market

Oral Drug Delivery Market

The global market for Oral Drug Delivery was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Oral drug delivery is the most preferred administration route due to noninvasive, high patient compliance, convenient to handle, and does not require any specific sterile conditions. However, some of the drugs administered orally face several physical, biological, and biochemical barriers which lower the therapeutic efficacy of the drugs before getting absorbed into the systemic circulation. The utilization of nanocarriers for oral drug delivery overcome abovementioned barriers and considered as an alternative strategy to address the drawbacks of oral drug delivery. In this chapter, the recent advancement of nanocarriers in oral drug delivery application for the treatment of various diseases is summarized. Furthermore, the chapter explains how different nanocarriers designing technology enhance the therapeutic potential to overcome the various barriers such as physical, biological, and biochemical. Although, in recent years, several nanocarrier-based drug delivery technologies have been evolved and showing promising results but still it is far from the real utilization in the clinic.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Oral Drug Delivery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Drug Delivery.
The Oral Drug Delivery market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Oral Drug Delivery market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oral Drug Delivery manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Oral Drug Delivery Market Report

Report Metric Details
Report Name Oral Drug Delivery Market
CAGR 5%
Segment by Type
Segment by Application
  • Hospitals
  • Clinics
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company AstraZeneca Plc., Mylan N.V., Sanofi, F. Hoffman-La-Roche Ltd., Bristol-Myers Squibb Company, Sun Pharmaceuticals Industries Ltd, Abbott Laboratories, Merck & Co. Inc., Novartis AG, Pfizer Inc., Vectura Group plc., GlaxoSmithKline plc., Johnson & Johnson Services, Inc
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Oral Drug Delivery manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Oral Drug Delivery in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Oral Drug Delivery Market report?

Ans: The main players in the Oral Drug Delivery Market are AstraZeneca Plc., Mylan N.V., Sanofi, F. Hoffman-La-Roche Ltd., Bristol-Myers Squibb Company, Sun Pharmaceuticals Industries Ltd, Abbott Laboratories, Merck & Co. Inc., Novartis AG, Pfizer Inc., Vectura Group plc., GlaxoSmithKline plc., Johnson & Johnson Services, Inc

What are the Application segmentation covered in the Oral Drug Delivery Market report?

Ans: The Applications covered in the Oral Drug Delivery Market report are Hospitals, Clinics, Other

What are the Type segmentation covered in the Oral Drug Delivery Market report?

Ans: The Types covered in the Oral Drug Delivery Market report are Diffusion Controlled Release System, Dissolution Controlled Release System, Ion Exchange Resins Controlled Release, Hydro-dynamically Balanced Drug Delivery System, Osmotically Controlled Release System, Dissolution & Diffusion Controlled Release System

Recommended Reports

Oral Drug Delivery

Drug Delivery Devices

Pharmaceutical Treatments

1 Oral Drug Delivery Market Overview
1.1 Product Definition
1.2 Oral Drug Delivery by Type
1.2.1 Global Oral Drug Delivery Market Value Comparison by Type (2024 VS 2031)
1.2.2 Diffusion Controlled Release System
1.2.3 Dissolution Controlled Release System
1.2.4 Ion Exchange Resins Controlled Release
1.2.5 Hydro-dynamically Balanced Drug Delivery System
1.2.6 Osmotically Controlled Release System
1.2.7 Dissolution & Diffusion Controlled Release System
1.3 Oral Drug Delivery by Application
1.3.1 Global Oral Drug Delivery Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Global Oral Drug Delivery Market Size Estimates and Forecasts
1.4.1 Global Oral Drug Delivery Revenue 2020-2031
1.4.2 Global Oral Drug Delivery Sales 2020-2031
1.4.3 Global Oral Drug Delivery Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Oral Drug Delivery Market Competition by Manufacturers
2.1 Global Oral Drug Delivery Sales Market Share by Manufacturers (2020-2025)
2.2 Global Oral Drug Delivery Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Oral Drug Delivery Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Oral Drug Delivery, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Oral Drug Delivery, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Oral Drug Delivery, Product Type & Application
2.7 Global Key Manufacturers of Oral Drug Delivery, Date of Enter into This Industry
2.8 Global Oral Drug Delivery Market Competitive Situation and Trends
2.8.1 Global Oral Drug Delivery Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Oral Drug Delivery Players Market Share by Revenue
2.8.3 Global Oral Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Oral Drug Delivery Market Scenario by Region
3.1 Global Oral Drug Delivery Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Oral Drug Delivery Sales by Region: 2020-2031
3.2.1 Global Oral Drug Delivery Sales by Region: 2020-2025
3.2.2 Global Oral Drug Delivery Sales by Region: 2026-2031
3.3 Global Oral Drug Delivery Revenue by Region: 2020-2031
3.3.1 Global Oral Drug Delivery Revenue by Region: 2020-2025
3.3.2 Global Oral Drug Delivery Revenue by Region: 2026-2031
3.4 North America Oral Drug Delivery Market Facts & Figures by Country
3.4.1 North America Oral Drug Delivery Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Oral Drug Delivery Sales by Country (2020-2031)
3.4.3 North America Oral Drug Delivery Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Oral Drug Delivery Market Facts & Figures by Country
3.5.1 Europe Oral Drug Delivery Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Oral Drug Delivery Sales by Country (2020-2031)
3.5.3 Europe Oral Drug Delivery Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Oral Drug Delivery Market Facts & Figures by Region
3.6.1 Asia Pacific Oral Drug Delivery Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Oral Drug Delivery Sales by Region (2020-2031)
3.6.3 Asia Pacific Oral Drug Delivery Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Oral Drug Delivery Market Facts & Figures by Country
3.7.1 Latin America Oral Drug Delivery Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Oral Drug Delivery Sales by Country (2020-2031)
3.7.3 Latin America Oral Drug Delivery Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Oral Drug Delivery Market Facts & Figures by Country
3.8.1 Middle East and Africa Oral Drug Delivery Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Oral Drug Delivery Sales by Country (2020-2031)
3.8.3 Middle East and Africa Oral Drug Delivery Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Oral Drug Delivery Sales by Type (2020-2031)
4.1.1 Global Oral Drug Delivery Sales by Type (2020-2025)
4.1.2 Global Oral Drug Delivery Sales by Type (2026-2031)
4.1.3 Global Oral Drug Delivery Sales Market Share by Type (2020-2031)
4.2 Global Oral Drug Delivery Revenue by Type (2020-2031)
4.2.1 Global Oral Drug Delivery Revenue by Type (2020-2025)
4.2.2 Global Oral Drug Delivery Revenue by Type (2026-2031)
4.2.3 Global Oral Drug Delivery Revenue Market Share by Type (2020-2031)
4.3 Global Oral Drug Delivery Price by Type (2020-2031)
5 Segment by Application
5.1 Global Oral Drug Delivery Sales by Application (2020-2031)
5.1.1 Global Oral Drug Delivery Sales by Application (2020-2025)
5.1.2 Global Oral Drug Delivery Sales by Application (2026-2031)
5.1.3 Global Oral Drug Delivery Sales Market Share by Application (2020-2031)
5.2 Global Oral Drug Delivery Revenue by Application (2020-2031)
5.2.1 Global Oral Drug Delivery Revenue by Application (2020-2025)
5.2.2 Global Oral Drug Delivery Revenue by Application (2026-2031)
5.2.3 Global Oral Drug Delivery Revenue Market Share by Application (2020-2031)
5.3 Global Oral Drug Delivery Price by Application (2020-2031)
6 Key Companies Profiled
6.1 AstraZeneca Plc.
6.1.1 AstraZeneca Plc. Company Information
6.1.2 AstraZeneca Plc. Description and Business Overview
6.1.3 AstraZeneca Plc. Oral Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
6.1.4 AstraZeneca Plc. Oral Drug Delivery Product Portfolio
6.1.5 AstraZeneca Plc. Recent Developments/Updates
6.2 Mylan N.V.
6.2.1 Mylan N.V. Company Information
6.2.2 Mylan N.V. Description and Business Overview
6.2.3 Mylan N.V. Oral Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Mylan N.V. Oral Drug Delivery Product Portfolio
6.2.5 Mylan N.V. Recent Developments/Updates
6.3 Sanofi
6.3.1 Sanofi Company Information
6.3.2 Sanofi Description and Business Overview
6.3.3 Sanofi Oral Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Sanofi Oral Drug Delivery Product Portfolio
6.3.5 Sanofi Recent Developments/Updates
6.4 F. Hoffman-La-Roche Ltd.
6.4.1 F. Hoffman-La-Roche Ltd. Company Information
6.4.2 F. Hoffman-La-Roche Ltd. Description and Business Overview
6.4.3 F. Hoffman-La-Roche Ltd. Oral Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
6.4.4 F. Hoffman-La-Roche Ltd. Oral Drug Delivery Product Portfolio
6.4.5 F. Hoffman-La-Roche Ltd. Recent Developments/Updates
6.5 Bristol-Myers Squibb Company
6.5.1 Bristol-Myers Squibb Company Company Information
6.5.2 Bristol-Myers Squibb Company Description and Business Overview
6.5.3 Bristol-Myers Squibb Company Oral Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Bristol-Myers Squibb Company Oral Drug Delivery Product Portfolio
6.5.5 Bristol-Myers Squibb Company Recent Developments/Updates
6.6 Sun Pharmaceuticals Industries Ltd
6.6.1 Sun Pharmaceuticals Industries Ltd Company Information
6.6.2 Sun Pharmaceuticals Industries Ltd Description and Business Overview
6.6.3 Sun Pharmaceuticals Industries Ltd Oral Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Sun Pharmaceuticals Industries Ltd Oral Drug Delivery Product Portfolio
6.6.5 Sun Pharmaceuticals Industries Ltd Recent Developments/Updates
6.7 Abbott Laboratories
6.7.1 Abbott Laboratories Company Information
6.7.2 Abbott Laboratories Description and Business Overview
6.7.3 Abbott Laboratories Oral Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Abbott Laboratories Oral Drug Delivery Product Portfolio
6.7.5 Abbott Laboratories Recent Developments/Updates
6.8 Merck & Co. Inc.
6.8.1 Merck & Co. Inc. Company Information
6.8.2 Merck & Co. Inc. Description and Business Overview
6.8.3 Merck & Co. Inc. Oral Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Merck & Co. Inc. Oral Drug Delivery Product Portfolio
6.8.5 Merck & Co. Inc. Recent Developments/Updates
6.9 Novartis AG
6.9.1 Novartis AG Company Information
6.9.2 Novartis AG Description and Business Overview
6.9.3 Novartis AG Oral Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Novartis AG Oral Drug Delivery Product Portfolio
6.9.5 Novartis AG Recent Developments/Updates
6.10 Pfizer Inc.
6.10.1 Pfizer Inc. Company Information
6.10.2 Pfizer Inc. Description and Business Overview
6.10.3 Pfizer Inc. Oral Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Pfizer Inc. Oral Drug Delivery Product Portfolio
6.10.5 Pfizer Inc. Recent Developments/Updates
6.11 Vectura Group plc.
6.11.1 Vectura Group plc. Company Information
6.11.2 Vectura Group plc. Description and Business Overview
6.11.3 Vectura Group plc. Oral Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Vectura Group plc. Oral Drug Delivery Product Portfolio
6.11.5 Vectura Group plc. Recent Developments/Updates
6.12 GlaxoSmithKline plc.
6.12.1 GlaxoSmithKline plc. Company Information
6.12.2 GlaxoSmithKline plc. Description and Business Overview
6.12.3 GlaxoSmithKline plc. Oral Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
6.12.4 GlaxoSmithKline plc. Oral Drug Delivery Product Portfolio
6.12.5 GlaxoSmithKline plc. Recent Developments/Updates
6.13 Johnson & Johnson Services, Inc
6.13.1 Johnson & Johnson Services, Inc Company Information
6.13.2 Johnson & Johnson Services, Inc Description and Business Overview
6.13.3 Johnson & Johnson Services, Inc Oral Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Johnson & Johnson Services, Inc Oral Drug Delivery Product Portfolio
6.13.5 Johnson & Johnson Services, Inc Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Oral Drug Delivery Industry Chain Analysis
7.2 Oral Drug Delivery Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Oral Drug Delivery Production Mode & Process Analysis
7.4 Oral Drug Delivery Sales and Marketing
7.4.1 Oral Drug Delivery Sales Channels
7.4.2 Oral Drug Delivery Distributors
7.5 Oral Drug Delivery Customer Analysis
8 Oral Drug Delivery Market Dynamics
8.1 Oral Drug Delivery Industry Trends
8.2 Oral Drug Delivery Market Drivers
8.3 Oral Drug Delivery Market Challenges
8.4 Oral Drug Delivery Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Astrazeneca plc
Mylan N.V.
Sanofi
F. Hoffman-La Roche Ltd.
Bristol Myers Squibb Company
Sun Pharmaceuticals Industries Ltd.
Abbott Laboratories
Merck& Co. Inc
Novartis
Pfizer Inc
Vectura Group plc
GlaxoSmithKline PLC
Johnson & Johnson Services Inc.
List of Tables
 Table 1. Global Oral Drug Delivery Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Oral Drug Delivery Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Oral Drug Delivery Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Oral Drug Delivery Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Oral Drug Delivery Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Oral Drug Delivery Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Oral Drug Delivery Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Oral Drug Delivery Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Oral Drug Delivery, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Oral Drug Delivery, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Oral Drug Delivery, Product Type & Application
 Table 12. Global Key Manufacturers of Oral Drug Delivery, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Oral Drug Delivery by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Drug Delivery as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Oral Drug Delivery Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Oral Drug Delivery Sales by Region (2020-2025) & (K Units)
 Table 18. Global Oral Drug Delivery Sales Market Share by Region (2020-2025)
 Table 19. Global Oral Drug Delivery Sales by Region (2026-2031) & (K Units)
 Table 20. Global Oral Drug Delivery Sales Market Share by Region (2026-2031)
 Table 21. Global Oral Drug Delivery Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Oral Drug Delivery Revenue Market Share by Region (2020-2025)
 Table 23. Global Oral Drug Delivery Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Oral Drug Delivery Revenue Market Share by Region (2026-2031)
 Table 25. North America Oral Drug Delivery Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Oral Drug Delivery Sales by Country (2020-2025) & (K Units)
 Table 27. North America Oral Drug Delivery Sales by Country (2026-2031) & (K Units)
 Table 28. North America Oral Drug Delivery Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Oral Drug Delivery Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Oral Drug Delivery Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Oral Drug Delivery Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Oral Drug Delivery Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Oral Drug Delivery Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Oral Drug Delivery Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Oral Drug Delivery Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Oral Drug Delivery Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Oral Drug Delivery Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Oral Drug Delivery Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Oral Drug Delivery Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Oral Drug Delivery Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Oral Drug Delivery Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Oral Drug Delivery Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Oral Drug Delivery Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Oral Drug Delivery Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Oral Drug Delivery Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Oral Drug Delivery Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Oral Drug Delivery Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Oral Drug Delivery Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Oral Drug Delivery Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Oral Drug Delivery Sales (K Units) by Type (2020-2025)
 Table 51. Global Oral Drug Delivery Sales (K Units) by Type (2026-2031)
 Table 52. Global Oral Drug Delivery Sales Market Share by Type (2020-2025)
 Table 53. Global Oral Drug Delivery Sales Market Share by Type (2026-2031)
 Table 54. Global Oral Drug Delivery Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Oral Drug Delivery Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Oral Drug Delivery Revenue Market Share by Type (2020-2025)
 Table 57. Global Oral Drug Delivery Revenue Market Share by Type (2026-2031)
 Table 58. Global Oral Drug Delivery Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Oral Drug Delivery Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Oral Drug Delivery Sales (K Units) by Application (2020-2025)
 Table 61. Global Oral Drug Delivery Sales (K Units) by Application (2026-2031)
 Table 62. Global Oral Drug Delivery Sales Market Share by Application (2020-2025)
 Table 63. Global Oral Drug Delivery Sales Market Share by Application (2026-2031)
 Table 64. Global Oral Drug Delivery Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Oral Drug Delivery Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Oral Drug Delivery Revenue Market Share by Application (2020-2025)
 Table 67. Global Oral Drug Delivery Revenue Market Share by Application (2026-2031)
 Table 68. Global Oral Drug Delivery Price (USD/Unit) by Application (2020-2025)
 Table 69. Global Oral Drug Delivery Price (USD/Unit) by Application (2026-2031)
 Table 70. AstraZeneca Plc. Company Information
 Table 71. AstraZeneca Plc. Description and Business Overview
 Table 72. AstraZeneca Plc. Oral Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. AstraZeneca Plc. Oral Drug Delivery Product
 Table 74. AstraZeneca Plc. Recent Developments/Updates
 Table 75. Mylan N.V. Company Information
 Table 76. Mylan N.V. Description and Business Overview
 Table 77. Mylan N.V. Oral Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. Mylan N.V. Oral Drug Delivery Product
 Table 79. Mylan N.V. Recent Developments/Updates
 Table 80. Sanofi Company Information
 Table 81. Sanofi Description and Business Overview
 Table 82. Sanofi Oral Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. Sanofi Oral Drug Delivery Product
 Table 84. Sanofi Recent Developments/Updates
 Table 85. F. Hoffman-La-Roche Ltd. Company Information
 Table 86. F. Hoffman-La-Roche Ltd. Description and Business Overview
 Table 87. F. Hoffman-La-Roche Ltd. Oral Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. F. Hoffman-La-Roche Ltd. Oral Drug Delivery Product
 Table 89. F. Hoffman-La-Roche Ltd. Recent Developments/Updates
 Table 90. Bristol-Myers Squibb Company Company Information
 Table 91. Bristol-Myers Squibb Company Description and Business Overview
 Table 92. Bristol-Myers Squibb Company Oral Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. Bristol-Myers Squibb Company Oral Drug Delivery Product
 Table 94. Bristol-Myers Squibb Company Recent Developments/Updates
 Table 95. Sun Pharmaceuticals Industries Ltd Company Information
 Table 96. Sun Pharmaceuticals Industries Ltd Description and Business Overview
 Table 97. Sun Pharmaceuticals Industries Ltd Oral Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 98. Sun Pharmaceuticals Industries Ltd Oral Drug Delivery Product
 Table 99. Sun Pharmaceuticals Industries Ltd Recent Developments/Updates
 Table 100. Abbott Laboratories Company Information
 Table 101. Abbott Laboratories Description and Business Overview
 Table 102. Abbott Laboratories Oral Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 103. Abbott Laboratories Oral Drug Delivery Product
 Table 104. Abbott Laboratories Recent Developments/Updates
 Table 105. Merck & Co. Inc. Company Information
 Table 106. Merck & Co. Inc. Description and Business Overview
 Table 107. Merck & Co. Inc. Oral Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 108. Merck & Co. Inc. Oral Drug Delivery Product
 Table 109. Merck & Co. Inc. Recent Developments/Updates
 Table 110. Novartis AG Company Information
 Table 111. Novartis AG Description and Business Overview
 Table 112. Novartis AG Oral Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 113. Novartis AG Oral Drug Delivery Product
 Table 114. Novartis AG Recent Developments/Updates
 Table 115. Pfizer Inc. Company Information
 Table 116. Pfizer Inc. Description and Business Overview
 Table 117. Pfizer Inc. Oral Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 118. Pfizer Inc. Oral Drug Delivery Product
 Table 119. Pfizer Inc. Recent Developments/Updates
 Table 120. Vectura Group plc. Company Information
 Table 121. Vectura Group plc. Description and Business Overview
 Table 122. Vectura Group plc. Oral Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 123. Vectura Group plc. Oral Drug Delivery Product
 Table 124. Vectura Group plc. Recent Developments/Updates
 Table 125. GlaxoSmithKline plc. Company Information
 Table 126. GlaxoSmithKline plc. Description and Business Overview
 Table 127. GlaxoSmithKline plc. Oral Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 128. GlaxoSmithKline plc. Oral Drug Delivery Product
 Table 129. GlaxoSmithKline plc. Recent Developments/Updates
 Table 130. Johnson & Johnson Services, Inc Company Information
 Table 131. Johnson & Johnson Services, Inc Description and Business Overview
 Table 132. Johnson & Johnson Services, Inc Oral Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 133. Johnson & Johnson Services, Inc Oral Drug Delivery Product
 Table 134. Johnson & Johnson Services, Inc Recent Developments/Updates
 Table 135. Key Raw Materials Lists
 Table 136. Raw Materials Key Suppliers Lists
 Table 137. Oral Drug Delivery Distributors List
 Table 138. Oral Drug Delivery Customers List
 Table 139. Oral Drug Delivery Market Trends
 Table 140. Oral Drug Delivery Market Drivers
 Table 141. Oral Drug Delivery Market Challenges
 Table 142. Oral Drug Delivery Market Restraints
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Oral Drug Delivery
 Figure 2. Global Oral Drug Delivery Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Oral Drug Delivery Market Share by Type: 2024 & 2031
 Figure 4. Diffusion Controlled Release System Product Picture
 Figure 5. Dissolution Controlled Release System Product Picture
 Figure 6. Ion Exchange Resins Controlled Release Product Picture
 Figure 7. Hydro-dynamically Balanced Drug Delivery System Product Picture
 Figure 8. Osmotically Controlled Release System Product Picture
 Figure 9. Dissolution & Diffusion Controlled Release System Product Picture
 Figure 10. Global Oral Drug Delivery Market Value by Application (2020-2031) & (US$ Million)
 Figure 11. Global Oral Drug Delivery Market Share by Application: 2024 & 2031
 Figure 12. Hospitals
 Figure 13. Clinics
 Figure 14. Other
 Figure 15. Global Oral Drug Delivery Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Oral Drug Delivery Market Size (2020-2031) & (US$ Million)
 Figure 17. Global Oral Drug Delivery Sales (2020-2031) & (K Units)
 Figure 18. Global Oral Drug Delivery Average Price (USD/Unit) & (2020-2031)
 Figure 19. Oral Drug Delivery Report Years Considered
 Figure 20. Oral Drug Delivery Sales Share by Manufacturers in 2024
 Figure 21. Global Oral Drug Delivery Revenue Share by Manufacturers in 2024
 Figure 22. Global 5 and 10 Largest Oral Drug Delivery Players: Market Share by Revenue in Oral Drug Delivery in 2024
 Figure 23. Oral Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 24. Global Oral Drug Delivery Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 25. North America Oral Drug Delivery Sales Market Share by Country (2020-2031)
 Figure 26. North America Oral Drug Delivery Revenue Market Share by Country (2020-2031)
 Figure 27. U.S. Oral Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Canada Oral Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Europe Oral Drug Delivery Sales Market Share by Country (2020-2031)
 Figure 30. Europe Oral Drug Delivery Revenue Market Share by Country (2020-2031)
 Figure 31. Germany Oral Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. France Oral Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. U.K. Oral Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Italy Oral Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Russia Oral Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Asia Pacific Oral Drug Delivery Sales Market Share by Region (2020-2031)
 Figure 37. Asia Pacific Oral Drug Delivery Revenue Market Share by Region (2020-2031)
 Figure 38. China Oral Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Japan Oral Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. South Korea Oral Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. India Oral Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Australia Oral Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Taiwan Oral Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Indonesia Oral Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Thailand Oral Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Malaysia Oral Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Philippines Oral Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Latin America Oral Drug Delivery Sales Market Share by Country (2020-2031)
 Figure 49. Latin America Oral Drug Delivery Revenue Market Share by Country (2020-2031)
 Figure 50. Mexico Oral Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Brazil Oral Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Argentina Oral Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Middle East and Africa Oral Drug Delivery Sales Market Share by Country (2020-2031)
 Figure 54. Middle East and Africa Oral Drug Delivery Revenue Market Share by Country (2020-2031)
 Figure 55. Turkey Oral Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Saudi Arabia Oral Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. U.A.E Oral Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 58. Global Sales Market Share of Oral Drug Delivery by Type (2020-2031)
 Figure 59. Global Revenue Market Share of Oral Drug Delivery by Type (2020-2031)
 Figure 60. Global Oral Drug Delivery Price (USD/Unit) by Type (2020-2031)
 Figure 61. Global Sales Market Share of Oral Drug Delivery by Application (2020-2031)
 Figure 62. Global Revenue Market Share of Oral Drug Delivery by Application (2020-2031)
 Figure 63. Global Oral Drug Delivery Price (USD/Unit) by Application (2020-2031)
 Figure 64. Oral Drug Delivery Value Chain
 Figure 65. Channels of Distribution (Direct Vs Distribution)
 Figure 66. Bottom-up and Top-down Approaches for This Report
 Figure 67. Data Triangulation
 Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Global Oral Controlled Release Drug Delivery Technology Market Research Report 2024
Nanotechnology Drug Delivery Systems Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Oral Mucosal Drug Delivery System Market Research Report 2024
Oral Transmucosal Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Oral Barrier Membrane Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Oral Drug Packaging Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Nanomedicine and Nanobiotechnology Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Drug Delivery Technology Market Research Report 2024
Global Nanoparticle Drug Delivery System Market Research Report 2024
Global Oral Peptide Therapy Market Research Report 2025
Liposomes Nanocarrier Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Novel Drug Delivery Systems for Cancer Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Oral Sustained and Controlled Release Formulations Market Research Report 2025
Drug Loaded Oral Thin Films Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Drug Delivery Technologies Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Radiopharmaceutical Oral Route Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Oral Anti allergic Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Oral Vaccine Delivery Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Oral Antifungals Market Insights Forecast to 2030
Global Oral Disintegrating Film Market Insights Forecast to 2030

RELATED REPORTS

Global Cephalosporin APIs and Cephalosporin Intermediates Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19G16926
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global ELISA Immunoassay Plates Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-7Z17064
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Ready-to-Use ELISA Kits Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-20P20045
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Moxidectin Injection Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3Z19977
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions